The long range goal of studies in the principal investigator's laboratory is to understand, in as precise molecular detail as possible, the mechanism(s) by which alpha2 adrenergic receptors couple to distinct effector systems (such as inhibition of adenylate cyclase, suppression of calcium currents, activation of potassium currents) to elicit their diverse regulatory effects on excitation-secretion coupling. This next phase of the research is based on the discovery that a mutation in a highly conserved residue in the receptor, Asp79Asn, resulted in a loss of allosteric regulation of the receptor to sodium and, more significantly, a selective loss in coupling of the receptor to potassium currents in AtT20 cells. The selective loss of response by the mutated receptors offers an excellent opportunity to explore the roles of hormonal responsive currents in suppression of peptide hormone release in these cells and to gain insight into basic coupling mechanisms of the receptor.
Specific aims i nclude: 1) Determination of the relative abilities of wildtype and various mutant receptors to suppress peptide hormone secretion via measurement of ACTH release form AtT20 cells. 2) Evaluation of a series of mutants in the Asp79 position of the alpha2 receptor with regard to allosteric modulation by cations and coupling to inhibition of adenylate cyclase, ion channels, and secretion. 3) Clarification of the molecular basis for perturbation of coupling of the D79N mutation to activation of potassium currents in the AtT20 cells as a means to reveal the G protein involved in coupling this and other similar receptors to potassium currents. 4) Identification of alpha2A-adrenergic receptor associated effector complexes involved in receptor mediated signal transduction by selective immuno-isolation of effector proteins with wildtype versus functionally modified mutant receptors. Overall, the PI believes that these studies will provide new molecular insights regarding alpha2- adrenergic coupling to diverse signal transduction mechanisms as a first step toward developing novel therapeutic agents that are targeted downstream of receptor occupancy, and may provide a degree of specificity for function not attainable by simultaneous modulation of activity at all alpha2 receptors of a given pharmacological type.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL025182-19
Application #
2838896
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1979-12-01
Project End
2000-11-30
Budget Start
1998-12-01
Budget End
2000-11-30
Support Year
19
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Lu, Roujian; Li, Yong; Zhang, Youwen et al. (2009) Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization. J Biol Chem 284:13233-43
Wang, Qin; Lu, Roujian; Zhao, Jiali et al. (2006) Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J Biol Chem 281:25948-55
Peng, Ning; Chambless, Brandon D; Oparil, Suzanne et al. (2003) Alpha2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus. Hypertension 41:571-5
Wilson, M H; Limbird, L E (2000) Mechanisms regulating the cell surface residence time of the alpha 2A-adrenergic receptor. Biochemistry 39:693-700
Schramm, N L; Limbird, L E (1999) Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis. J Biol Chem 274:24935-40
Edwards, S W; Limbird, L E (1999) Role for the third intracellular loop in cell surface stabilization of the alpha2A-adrenergic receptor. J Biol Chem 274:16331-6
Lakhlani, P P; MacMillan, L B; Guo, T Z et al. (1997) Substitution of a mutant alpha2a-adrenergic receptor via ""hit and run"" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 94:9950-5
Lakhlani, P P; Lovinger, D M; Limbird, L E (1996) Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling. Mol Pharmacol 50:96-103
Ceresa, B P; Limbird, L E (1994) Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic recepto J Biol Chem 269:29557-64
Keefer, J R; Nunnari, J; Pang, I H et al. (1994) Introduction of purified alpha 2A-adrenergic receptors into uniformly oriented, unilamellar, phospholipid vesicles: productive coupling to G proteins but lack of receptor-dependent ion transport. Mol Pharmacol 45:1071-81

Showing the most recent 10 out of 32 publications